🚀 Gate Square “Gate Fun Token Challenge” is Live!
Create tokens, engage, and earn — including trading fee rebates, graduation bonuses, and a $1,000 prize pool!
Join Now 👉 https://www.gate.com/campaigns/3145
💡 How to Participate:
1️⃣ Create Tokens: One-click token launch in [Square - Post]. Promote, grow your community, and earn rewards.
2️⃣ Engage: Post, like, comment, and share in token community to earn!
📦 Rewards Overview:
Creator Graduation Bonus: 50 GT
Trading Fee Rebate: The more trades, the more you earn
Token Creator Pool: Up to $50 USDT per user + $5 USDT for the first 50 launche
The medical equipment company STSS has hoarded 2 million SOL in its treasury, earning 17.7 million dollars in Q3 from staking.
[BitPush] The US medical device company Sharps Technology ( STSS ) has just released an interesting Q3 report - this company, which originally focused on the syringe business, has now completely transformed into a heavy position player in SOL.
First, let's talk about money. They raised $411 million through PIPE financing, of which $267 million is in cash and stablecoins, and the remaining $144 million is directly in SOL tokens. As of the end of October, the company's treasury has hoarded over 2 million SOL.
In the three months of Q3, relying solely on staking rewards and unrealized gains from digital assets, STSS earned 17.7 million USD. The liquidity on hand is also decent, with cash and stablecoins totaling 25.2 million at the end of September.
Chairman Paul K. Danner said it quite frankly: using Solana for financial strategy in conjunction with this round of financing has given the company the strongest balance sheet in history. They have completely bid farewell to traditional syringe manufacturing, and are now focused on two things – medical equipment distribution and squeezing the value out of the SOL treasury.
A medical company all in SOL, this approach is indeed quite wild.